📢 Press release IBA Industrial Solutions has signed a contract with BENEBION, a sterilization service provider, to install a Rhodotron® TT1000 at the new cutting-edge irradiation site in San Luis Potosí, Mexico. The facility will function as a service center for phytosanitary treatments and medical device sterilization in the region. 🔗 Read the full press release here: https://lnkd.in/eag3C5Rg
Congrats!
Read this insightful Q&A with our experts Bryce Telford, Helin Räägel, PhD, and Lee Wence, discussing vaporized hydrogen peroxide (VH2O2) as a sterilization option. Find the link to the article in the MPO post below (under "Learn More").
Medical Product Outsourcing's own Sean Fenske sits down with a trio of experts from Nelson Labs in this informative Q&A to discuss the use of Vaporized Hydrogen Peroxide (VH2O2) for device sterilization. The questions swirling around medical device sterilization have raised interest in the identification and use of alternatives. Learn More: https://hubs.li/Q02HJ87j0 Sponsored by Nelson Labs
Advanced Sterilization Products, in collaboration with PENTAX Medical, a division of HOYA Group, proudly announces the FDA clearance of the new ULTRA GI™ Cycle in its flagship product, the STERRAD™ 100NX Sterilizer with ALLClear™ Technology. The ULTRA GI™ Cycle is specifically and uniquely designed to reprocess duodenoscopes using hydrogen peroxide gas plasma sterilization. The FDA clearance marks a significant milestone in advancing patient safety and addressing the challenges associated with current reprocessing methods for duodenoscopes. This groundbreaking sterilization cycle is set to revolutionize sterilization practices in healthcare facilities, ensuring a new standard of safety and efficacy. Learn more about the ULTRA GI™ Cycle by reading the press release now: asplink.co/ultra-gi-cycle #AdvancedSterilizationProducts #PressRelease #NewProduct #SterileProcessing #InfectionPrevention
Sponsored Content Advanced Sterilization Products (ASP), in collaboration with PENTAX Medical Americas, is excited to announce FDA clearance for an innovative cycle designed to reprocess duodenoscopes into STERRAD™ 100NX System with ALLClear™ Technology. This new cycle, known as the ULTRA GI™Cycle uses hydrogen peroxide gas plasma, effectively addressing contamination challenges and significantly enhancing patient safety. Duodenoscopes have faced ongoing scrutiny due to high contamination rates, creating significant challenges in healthcare settings. The revolutionary ULTRA GI™Cycle tackles these challenges directly, offering a powerful sterilization method that not only meets but exceeds industry standards. ASP is currently partnering with several medical device manufacturers to develop a new generation of GI scopes compatible with the STERRAD™100NX Sterilizer, set to launch in European countries soon.* What does it mean? 🌟 Enhanced Patient Safety: Setting a new standard in sterilization that reduces contamination risks. 🌍 Environmental Sustainability: A safer solution for patients, technicians, and the environment. 🤝 Successful Collaboration: An outstanding achievement thanks to ASP partnership with PENTAX Medical. Read the full Press Release here: https://lnkd.in/evRUYc2C *Pending CE mark update #WeAreASP #InfectionPrevention #PatientSafety
Marketing Leader / Infection Prevention / Medical Devices / Patient Centricity / Launch Excellence / Digital Transformation
In #AdvancedSterilizationProducts we have a track record of breakthrough innovation! Same as when the STERRAD™ Systems were introduced, now a new cycle is coming to sterilize GI endoscopes and set new standards for patients, by reducing the risk of contamination due to insufficient instrument reprocessing.
Sponsored Content Advanced Sterilization Products (ASP), in collaboration with PENTAX Medical Americas, is excited to announce FDA clearance for an innovative cycle designed to reprocess duodenoscopes into STERRAD™ 100NX System with ALLClear™ Technology. This new cycle, known as the ULTRA GI™Cycle uses hydrogen peroxide gas plasma, effectively addressing contamination challenges and significantly enhancing patient safety. Duodenoscopes have faced ongoing scrutiny due to high contamination rates, creating significant challenges in healthcare settings. The revolutionary ULTRA GI™Cycle tackles these challenges directly, offering a powerful sterilization method that not only meets but exceeds industry standards. ASP is currently partnering with several medical device manufacturers to develop a new generation of GI scopes compatible with the STERRAD™100NX Sterilizer, set to launch in European countries soon.* What does it mean? 🌟 Enhanced Patient Safety: Setting a new standard in sterilization that reduces contamination risks. 🌍 Environmental Sustainability: A safer solution for patients, technicians, and the environment. 🤝 Successful Collaboration: An outstanding achievement thanks to ASP partnership with PENTAX Medical. Read the full Press Release here: https://lnkd.in/evRUYc2C *Pending CE mark update #WeAreASP #InfectionPrevention #PatientSafety
Contrast Media Injectors Market Size to Hit USD 2.3 Billion by 2029 📑 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐏𝐃𝐅: https://lnkd.in/dJHZT784 The size of global contrast media injectors market in terms of revenue was estimated to be worth $1.6 billion in 2024 and is poised to reach $2.3 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bayer Bracco Imaging Korea Guerbet ULRICH GMBH & CO. KG MEDTRON AG Nemoto Portugal, Química Fina, Unipessoal, Lda. Shenzhen Anke High-Tech Co.,Ltd. APOLLO RT Corporation Limited Shenzhen Seacrown Electromechanical Co., Ltd. Shenzhen Antmed Co., Ltd. Union Medical Shenzhen Co., Ltd. Spectrum Medical Technologies Shenzhen Boon Medical Supply Co.LTD SCW Medicath VYGON Nanjing Foinoe Co.,LTD Lemer Pax Comecer Tema Sinergie Qingdao Hiprove Medical Technologies Co.,Ltd. Shanghai Kindly Enterprise Development Group Co., Ltd
Hospital Account Manager | Expert in Building Long-term Customer Relationships and Achieving Sales Targets
Confirmation testing is crucial in situations like this to ensure the safety of your patients. It helps verify the presence and quantity of harmful substances like fentanyl, preventing potentially lethal outcomes. Choosing Aegis Sciences ensures reliable and accurate testing results to provide you the whole story when treating your patients. Better understanding allows for more precise treatment decisions. #aegislabs #recoveryispossible #recoverymonth #fentanylawareness #preventoverdose
#DEA lab testing reveals 7 out of 10 fentanyl-laced fake Rx pills analyzed in 2023 now contain a potentially lethal dose of fentanyl. Just 2 mg of fentanyl, a small amount that fits on a pencil tip, is considered a potentially deadly dose. #OnePillCanKill DEA.gov/onepill
#DEA lab testing reveals 5 out of 10 fentanyl-laced fake Rx pills analyzed in 2024 now contain a potentially lethal dose of fentanyl. Just 2 mg of fentanyl, a small amount that fits on a pencil tip, is considered a potentially deadly dose. #OnePillCanKill DEA.gov/onepill
Werfen’s GEM Premier 7000 with iQM3*—the first, point-of-care blood gas testing system with integrated hemolysis detection—has been honored with four prestigious awards; including three Excellence Awards, recognizing the most notable medical device advancements, and the 2024 R&D 100 Award, recognizing the technological significance of new products worldwide. Discover what makes this system a breakthrough in blood gas testing: https://hubs.ly/Q02Z5q5l0 #MedicalExcellence #HealthcareInnovation *Not available in all countries.
Good knowledge-
#DEA lab testing reveals 7 out of 10 fentanyl-laced fake Rx pills analyzed in 2023 now contain a potentially lethal dose of fentanyl. Just 2 mg of fentanyl, a small amount that fits on a pencil tip, is considered a potentially deadly dose. #OnePillCanKill Learn more: DEA.gov/onepill
Fentanyl is so dangerous.
#DEA lab testing reveals 7 out of 10 fentanyl-laced fake Rx pills analyzed in 2023 now contain a potentially lethal dose of fentanyl. Just 2 mg of fentanyl, a small amount that fits on a pencil tip, is considered a potentially deadly dose. #OnePillCanKill DEA.gov/onepill
We are looking forward to a fantastic partnership! Thanks for all the hard work that went into structuring the deal.